PRE Strangle Strategy
PRE (Prenetics Global Limited), in the Healthcare sector, (Medical - Diagnostics & Research industry), listed on NASDAQ.
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
PRE (Prenetics Global Limited) trades in the Healthcare sector, specifically Medical - Diagnostics & Research, with a market capitalization of approximately $246.9M, a beta of 0.15 versus the broader market, a 52-week range of 5.58-23.63, average daily share volume of 216K, a public-listing history dating back to 2021, approximately 285 full-time employees. These structural characteristics shape how PRE stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.15 indicates PRE has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a strangle on PRE?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current PRE snapshot
As of May 14, 2026, spot at $17.52, ATM IV 74.70%, IV rank 20.79%, expected move 21.42%. The strangle on PRE below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this strangle structure on PRE specifically: PRE IV at 74.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a PRE strangle, with a market-implied 1-standard-deviation move of approximately 21.42% (roughly $3.75 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated PRE expiries trade a higher absolute premium for lower per-day decay. Position sizing on PRE should anchor to the underlying notional of $17.52 per share and to the trader's directional view on PRE stock.
PRE strangle setup
The PRE strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With PRE near $17.52, the first option leg uses a $18.40 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed PRE chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 PRE shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $18.40 | N/A |
| Buy 1 | Put | $16.64 | N/A |
PRE strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
PRE strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on PRE. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on PRE
Strangles on PRE are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the PRE chain.
PRE thesis for this strangle
The market-implied 1-standard-deviation range for PRE extends from approximately $13.77 on the downside to $21.27 on the upside. A PRE long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current PRE IV rank near 20.79% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on PRE at 74.70%. As a Healthcare name, PRE options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to PRE-specific events.
PRE strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. PRE positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move PRE alongside the broader basket even when PRE-specific fundamentals are unchanged. Always rebuild the position from current PRE chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on PRE?
- A strangle on PRE is the strangle strategy applied to PRE (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With PRE stock trading near $17.52, the strikes shown on this page are snapped to the nearest listed PRE chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are PRE strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the PRE strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 74.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a PRE strangle?
- The breakeven for the PRE strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current PRE market-implied 1-standard-deviation expected move is approximately 21.42%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on PRE?
- Strangles on PRE are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the PRE chain.
- How does current PRE implied volatility affect this strangle?
- PRE ATM IV is at 74.70% with IV rank near 20.79%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.